Japan issues patent on anti-MRSA antibodies

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, announced that the Japan Patent Office has issued Japanese patent number 5,837,215 covering monoclonal antibody compositions that bind and neutralize the endo-I^2-N-acetylglucosaminidase (Gmd) subunit of staphylococcal bifunctional autolysin and methods to use those antibodies for the treatment and ["]